Ammonia Aerosol
NDC Package 68599-7100-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Ammonia (inhalant) aerosols is a medication used to treat or prevent fainting. This formulation utilizes a aerosol delivery system. Marketed by Mckesson, this product is identified by NDC 68599-7100.

Identification & Billing

NDC Package Code
68599-7100-1
Package Description
.15 g in 1 BOX
Product Code
11-Digit Billing Format
68599710001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ammonia
Non-Proprietary Name
Inhalant
Substance Name
Ammonia
Dosage Form
Aerosol - A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols).
Administration Route
Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
Active Ingredient(s)
Usage Information
This product is used to treat or prevent fainting. It works by increasing the body's urge to breathe.

Regulatory & Marketing

Labeler Name
Mckesson
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-16-2020
End Marketing Date
09-01-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68599-7100-1 identifies a specific commercial package of .15 g in 1 box of Ammonia, a human over the counter drug labeled by Mckesson. This aerosol is formulated for respiratory (inhalation) use and contains ammonia as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson on January 16, 2020.

What are the primary indications for this medication?

This product is used to treat or prevent fainting. It works by increasing the body's urge to breathe.

How is this Mckesson product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68599710001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68599-7100-1
11-Digit CMS (5-4-2)
68599-7100-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.